Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma

Up to 50% of oral squamous cell carcinomas (OSCCs) recur following surgical resections with conventional “histologically-negative” margins. Three members of the SIBLING (Small Integrin Binding LIgand N-linked Gylcoprotein) family of proteins: dentin sialophophoprotein (DSPP); bone sialoprotein (BSP); and osteopontin OPN are upregulated in OSCCs. In this study, we aimed to correlate the expression of DSPP, OPN and BSP as well as three SIBLING-partners, matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-3 (MMP-3), and matrix metalloproteinase-9 (MMP-9), at histologically-negative margins of OSCCs with tumor recurrence. Immunohistochemical analyses of the SIBLINGs and MMP expressions at histologically-negative margins of OSCC was carried out in a retrospective study of 20 patients, and the results correlated with tumor recurrence. Each protein was dichotomized as “present” (≥10% staining) or “absent” (< 10% staining). The Sensitivity, Specificity, Positive Predictive Value(PV+) and Negative Predictive Value (PV−) for recurrence was calculated for each protein, along with their overall diagnostic accuracy, calculated as: (number of true positives + number of true negatives)/ number of patients. OSCC recurred in 9 of 20 patients (45%), a ratio not significantly different from the estimated population recurrence rate of 50% (p = 0.664). Among the SIBLINGs, DSPP and OPN showed the greatest Accuracy with DSPP being more Sensitive (89%) and OPN more Specific (64%). MMP-9 showed the greatest overall Accuracy (80%), slightly less Sensitivity (67%) and more Specificity (100%), than either DSPP or OPN. MMP-9 showed a superior positive PV than either DSPP or OPN. The negative PVs of OPN and MMP-9 were almost identical, and inferior to DSPP. We conclude that DSPP, OPN, or MMP-9 expressions at histologically-negative surgical margins predict OSCC recurrence with MMP-9 being the preferred predictor. These proteins may identify patients who could benefit from more extensive resection, or from adjunct treatments such as radiotherapy.

[1]  J. Langdon,et al.  Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  N. Fedarko,et al.  Six Genes Expressed in Bones and Teeth Encode the Current Members of the SIBLING Family of Proteins , 2003, Connective tissue research.

[3]  K. Ogbureke,et al.  Expression of SIBLINGs and Their Partner MMPs in Salivary Glands , 2004, Journal of dental research.

[4]  V. Castronovo,et al.  Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer , 2008, Nature Reviews Cancer.

[5]  K. Ogbureke,et al.  Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). , 2005, Kidney international.

[6]  R. Spiro,et al.  Pattern of invasion and margin assessment in patients with oral tongue cancer , 1999, Head & neck.

[7]  S. Radpour,et al.  p53 Immunostaining of Surgical Margins as a Predictor of Local Recurrence in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx , 1997, Ear, nose, & throat journal.

[8]  L Michaels,et al.  The uncertainty of the surgical margin in the treatment of head and neck cancer. , 2007, Oral oncology.

[9]  F. Abreo,et al.  Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. , 2000, Cancer research.

[10]  R. Shi,et al.  Molecular Analysis of Surgical Margins in Head and Neck Squamous Cell Carcinoma Patients , 2002, The Laryngoscope.

[11]  A. De Benedetti,et al.  Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Garnis,et al.  A Dynamic Oral Cancer Field: Unraveling the Underlying Biology and Its Clinical Implication , 2009, The American journal of surgical pathology.

[13]  K. Ogbureke,et al.  Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma , 2010, Cancer.

[14]  I. Zlobec,et al.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget , 2010, Oncotarget.

[15]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[16]  G. Snow,et al.  Implant dentistry: Association between periodontal and peri-implant conditions: a 10-year prospective study , 2004, British Dental Journal.

[17]  N. Nikitakis,et al.  Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer. , 2007, Oral oncology.

[18]  C. R. Leemans,et al.  Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. , 2005, Seminars in cancer biology.

[19]  G. Caldito,et al.  Overexpressed eIF4E Is Functionally Active in Surgical Margins of Head and Neck Cancer Patients via Activation of the Akt/Mammalian Target of Rapamycin Pathway , 2004, Clinical Cancer Research.

[20]  E. Gabrielson,et al.  Multiple head and neck tumors: evidence for a common clonal origin. , 1996, Cancer research.

[21]  T. Loree,et al.  Cancer of the buccal mucosa: are margins and T-stage accurate predictors of local control? , 2001, American journal of otolaryngology.

[22]  N. Fedarko,et al.  Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Jing Yang,et al.  Targeting invadopodia to block breast cancer metastasis , 2011, Oncotarget.

[24]  G. Snow,et al.  Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy , 2000, Head & neck.